AlzChem Group AG (ACT.F)
- Previous Close
43.00 - Open
45.10 - Bid 45.30 x --
- Ask 45.80 x --
- Day's Range
45.10 - 45.90 - 52 Week Range
17.70 - 47.30 - Volume
1,300 - Avg. Volume
379 - Market Cap (intraday)
463.022M - Beta (5Y Monthly) 1.10
- PE Ratio (TTM)
13.38 - EPS (TTM)
3.40 - Earnings Date Apr 30, 2024
- Forward Dividend & Yield 1.20 (2.64%)
- Ex-Dividend Date May 8, 2024
- 1y Target Est
44.10
AlzChem Group AG, together with its subsidiaries, develops, produces, and trades chemical products in Germany, European Union, rest of Europe, Asia, NAFTA region, and internationally. It operates through three segments: Specialty Chemicals, Basics & Intermediates, and Other & Holding. The company offers dietary supplements under the Creapure and Alipure brands; preparation of guanidinoacetic acid as a nutritional feed additives under the Creamino brand; creatine dietary supplements under the LIVADUR brand; products for pharmaceuticals under the Bioselect brand; curing agents, including accelerators for use in adhesives, powder coatings, printed circuit boards, and composites under the DYHARD name; and silicon nitride for ceramics, and electronics and solar applications under the SILZOT brand. It also provides fine and specialty chemicals, including products based on calcium carbide, calcium cyanamide, hydrogen cyanamide, dicyandiamide, guanidine, guanamines, and nitroguanidine, as well as aromatic and aliphatic nitriles; calcium cyanamide under the PERLKA name; germicide for use in pig pens under the ALZOGUR name; plant growth regulators under the Dormex and Sitofex name; and plant protection additives under the BREAK-THRU name. In addition, the company offers products for use in hot metal desulfurization and secondary metallurgy applications; and technical gases. Further, it provides chemical park operations and administrative services, as well as produces and distributes various infrastructure services. The company was founded in 1908 and is based in Trostberg, Germany.
www.alzchem.com1,506
Full Time Employees
December 31
Fiscal Year Ends
Sector
Industry
Recent News: ACT.F
Performance Overview: ACT.F
Trailing total returns as of 4/26/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: ACT.F
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: ACT.F
Valuation Measures
Market Cap
463.02M
Enterprise Value
511.59M
Trailing P/E
13.38
Forward P/E
10.99
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
0.86
Price/Book (mrq)
2.86
Enterprise Value/Revenue
0.95
Enterprise Value/EBITDA
6.26
Financial Highlights
Profitability and Income Statement
Profit Margin
6.34%
Return on Assets (ttm)
7.94%
Return on Equity (ttm)
22.48%
Revenue (ttm)
545.79M
Net Income Avi to Common (ttm)
34.62M
Diluted EPS (ttm)
3.40
Balance Sheet and Cash Flow
Total Cash (mrq)
11.88M
Total Debt/Equity (mrq)
38.21%
Levered Free Cash Flow (ttm)
46.82M
Research Analysis: ACT.F
Company Insights: ACT.F
ACT.F does not have Company Insights